86 related articles for article (PubMed ID: 8623210)
1. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy.
Loss M; Winkler M; Schneider A; Oldhafer K; Manns MP; Pichlmayr R
Transplant Proc; 1996 Apr; 28(2):1006-7. PubMed ID: 8623210
[No Abstract] [Full Text] [Related]
2. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
Loss M; Winkler M; Schneider A; Brinkmann C; Manns M; Ringe B; Pichlmayr R
Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
[No Abstract] [Full Text] [Related]
3. Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation.
Wierzbicka A; Pawłowska J; Socha P; Jankowska I; Skorupa E; Teisseyre M; Ismail H; Czubkowski P; Socha J
Transplant Proc; 2007 Jun; 39(5):1523-5. PubMed ID: 17580179
[TBL] [Abstract][Full Text] [Related]
4. The effect of cyclosporine vs FK 506 on glucose metabolism.
Steinmueller T; Konrad T; Jonas S; Tullius S; Bechstein WO; Mueller A; Platz KP; Neumann U; Vicini P; Toffolo G; Cobelli C; Usadel KH; Neuhaus P
Transplant Proc; 1999; 31(1-2):1129-30. PubMed ID: 10083504
[No Abstract] [Full Text] [Related]
5. [Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?].
Petrides AS
Z Gastroenterol; 1995 Jul; 33(7):414-5. PubMed ID: 7571761
[No Abstract] [Full Text] [Related]
6. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy.
Konrad T; Steinmüller T; Vicini P; Toffolo G; Grewerus D; Schüller A; Bechstein WO; Usadel KH; Cobelli C; Neuhaus P
Transplantation; 2000 May; 69(10):2072-8. PubMed ID: 10852599
[TBL] [Abstract][Full Text] [Related]
7. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
[TBL] [Abstract][Full Text] [Related]
8. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
9. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
[TBL] [Abstract][Full Text] [Related]
10. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation.
Golling M; Lehmann T; Senninger N; Herfarth C; Otto G
Transplant Proc; 1996 Dec; 28(6):3180-2. PubMed ID: 8962234
[No Abstract] [Full Text] [Related]
12. Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine.
Armstrong VW; Kaltefleiter M; Luy-Kaltefleiter M; Schütz E; Wieland E; Loss M; Winkler M; Ringe B; Oellerich M
Transplant Proc; 1995 Feb; 27(1):1201-3. PubMed ID: 7533371
[No Abstract] [Full Text] [Related]
13. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
[TBL] [Abstract][Full Text] [Related]
14. Effect of CsA versus FK 506 on insulin sensitivity and insulin response using a modeling technique.
Steinmueller T; Konrad T; Vicini P; Toffolo G; Jonas S; Tullius S; Bechstein WO; Cobelli C; Usadel KH; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1452-3. PubMed ID: 9636589
[No Abstract] [Full Text] [Related]
15. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
[TBL] [Abstract][Full Text] [Related]
16. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
White M; Haddad H; Leblanc MH; Giannetti N; Pflugfelder P; Davies R; Isaac D; Burton J; Chan M; Azevedo E; Howlett J; Ignaszewski A; Busque S; Cantarovich M; Ferguson R; Genest J; Ross H
J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
[TBL] [Abstract][Full Text] [Related]
17. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J
Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214
[No Abstract] [Full Text] [Related]
18. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.
Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P
Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
Andrews WS; Sommerauer J; Conlin C; Moore P
Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
[No Abstract] [Full Text] [Related]
20. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
